Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,044 | -84,936 | -38,253 | -31,209 | -16,002 |
| Depreciation Amortization | 1,113 | 4,464 | 3,268 | 2,184 | 1,085 |
| Accounts receivable | 3,000 | -3,000 | N/A | N/A | N/A |
| Other Working Capital | -1,155 | -18,263 | 907 | -693 | -743 |
| Other Operating Activity | 5,399 | 36,070 | -1,330 | 4,644 | 2,075 |
| Operating Cash Flow | $-13,687 | $-65,665 | $-35,408 | $-25,074 | $-13,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,178 | 70,213 | 58,966 | 31,801 | 9,820 |
| PPE Investments | -103 | -4,151 | -903 | -501 | -444 |
| Investing Cash Flow | $1,075 | $66,062 | $58,063 | $31,300 | $9,376 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 24,861 | 8,530 | 8,357 | 5,878 |
| Financing Cash Flow | $N/A | $24,861 | $8,530 | $8,357 | $5,878 |
| Beginning Cash Position | 38,829 | 13,571 | 13,571 | 13,571 | 13,571 |
| End Cash Position | 26,217 | 38,829 | 44,756 | 28,154 | 15,240 |
| Net Cash Flow | $-12,612 | $25,258 | $31,185 | $14,583 | $1,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,687 | -65,665 | -35,408 | -25,074 | -13,585 |
| Capital Expenditure | -103 | -4,151 | -903 | -501 | -444 |
| Free Cash Flow | -13,790 | -69,816 | -36,311 | -25,575 | -14,029 |